Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational Observational Study to Evaluate the Safety of Repatha® in Pregnancy

NCT02906124 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02906124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02906124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational Observational Study to Evaluate the Safety of Repatha® in Pregnancy
Lead sponsor
Amgen
Phase
Observational
Overall status
Terminated
Start date
January 12, 2017
Completion date
November 6, 2020
Enrollment
4 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolaemia, pregnancy